1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31680
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOlaiya, Muideen T-
dc.contributor.authorAndrew, Nadine E-
dc.contributor.authorDalli, Lachlan L-
dc.contributor.authorUng, David-
dc.contributor.authorKim, Joosup-
dc.contributor.authorCadilhac, Dominique A-
dc.contributor.authorWood, Peter-
dc.contributor.authorMay, Janet-
dc.contributor.authorClissold, Ben-
dc.contributor.authorKilkenny, Monique F-
dc.date2022-
dc.date.accessioned2023-01-12T02:00:02Z-
dc.date.available2023-01-12T02:00:02Z-
dc.date.issued2022-
dc.identifier.citationNeuroepidemiology 2022en_US
dc.identifier.issn1423-0208-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31680-
dc.description.abstractObservational studies are increasingly being used to provide evidence on the real-world effectiveness of medications for preventing vascular diseases, such as stroke. We investigated whether the real-world effectiveness of treatment with lipid-lowering medications after ischemic stroke is affected by prevalent-user bias.en_US
dc.language.isoeng-
dc.subjectAdherenceen_US
dc.subjectBiasen_US
dc.subjectMortalityen_US
dc.subjectOutcomesen_US
dc.subjectSecondary preventionen_US
dc.subjectStrokeen_US
dc.titleReal-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleNeuroepidemiologyen_US
dc.identifier.affiliationDepartment of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.en_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationDivision of Medicine, Queensland Health, Brisbane, Queensland, Australia.en_US
dc.identifier.affiliationLatrobe Regional Hospital, Traralgon West, Victoria, Australia.en_US
dc.identifier.doi10.1159/000526071en_US
dc.type.contentTexten_US
dc.identifier.pubmedid35863320-
dc.description.volume56-
dc.description.issue5-
dc.description.startpage365-
dc.description.endpage372-
dc.subject.meshtermssecondaryAustralia/epidemiology-
dc.subject.meshtermssecondaryStroke/drug therapy-
dc.subject.meshtermssecondaryStroke/epidemiology-
dc.subject.meshtermssecondaryLipids/therapeutic use-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Mar 10, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.